Risk of Maternal Depression From 1 Year to 4 Years Postpartum in Yvelines
Launched by CENTRE MÉDICAL PORTE VERTE · Sep 15, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the risk of postpartum depression in women living in Yvelines, France, between one and four years after giving birth. Researchers want to understand how common this condition is during this time and identify factors that may contribute to it. To do this, they will use two questionnaires, the Edinburgh Postnatal Depression Scale (EPDS) and the Patient Health Questionnaire 2 (PHQ2), to assess the mental health of participants.
To be eligible for the study, women must be over 18, have had a child between one and four years ago, and live in Yvelines. They should also be able to speak, read, and write in French. Participants will need to agree to take part in the study. However, women who experienced postpartum depression in the first year after giving birth, are currently pregnant, or do not meet the other criteria cannot participate. If you join the study, you’ll fill out the questionnaires to help researchers learn more about postpartum depression, which can lead to better support for mothers in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women over 18 years old
- • Women from 1 year to 4 years postpartum or having children aged from 1 to 4 years old
- • Patient gave their consent to participate in the study
- • Patient lives in Yvelines
- • Patient speaks and understands French
- • Patient reads and writes in French
- Exclusion Criteria:
- • Patient suffered from postpartum depression in the 1st year after giving birth or is currently being treated for postpartum depression that started showing symptoms in the 1st year after giving birth.
- • Patient is currently pregnant
- • Patient gave birth less than 1 year prior or more than 4 years prior; or has a child who is less than one year old; or 5 or more years old
- • Patient didn't give her consent to participate in the study
- • Patient is under guardianship or judicial safeguard
About Centre Médical Porte Verte
Centre Médical Porte Verte is a leading clinical research organization dedicated to advancing healthcare through innovative clinical trials. With a commitment to excellence and patient-centered care, the center specializes in a wide range of therapeutic areas, fostering collaboration between healthcare professionals, researchers, and participants. Equipped with state-of-the-art facilities and a team of experienced clinicians, Centre Médical Porte Verte aims to facilitate the development of safe and effective medical treatments while ensuring the highest standards of ethical compliance and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Versailles, île De France, France
Versailles, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported